Citation 81523

EL-MEKKAWY,S: MESELHY,MR: NAKAMURA,N: TEZUKA,Y: HATTORI,M: KAKIUCHI,N: SHIMOTOHNO,K: KAWAHATA,T: OTAKE,T:. (1998). ANTI-HIV-1 AND ANTI-HIV-1-PROTEASE SUBSTANCES FROM GANODERMA LUCIDUM.. 49(6)

Citation Details

Title	ANTI-HIV-1 AND ANTI-HIV-1-PROTEASE SUBSTANCES FROM GANODERMA LUCIDUM.
Authors	EL-MEKKAWY,S: MESELHY,MR: NAKAMURA,N: TEZUKA,Y: HATTORI,M: KAKIUCHI,N: SHIMOTOHNO,K: KAWAHATA,T: OTAKE,T:
Year	1998
Volume	49
Issue	6

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Ganoderma lucidum (GANODERMATACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GANODERIC ACID ALPHA	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	WEAK ACTIVITY
3	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	WEAK ACTIVITY
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERIC ACID ALPHA	INACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GANODERIC ACID ALPHA	INACTIVE
6	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIC ACID ALPHA	WEAK ACTIVITY
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GANODERIC ACID A	None
8	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERIC ACID A	INACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GANODERIC ACID A	INACTIVE
10	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIC ACID A	INACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GANODERIC ACID B	None
12	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERIC ACID B	INACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GANODERIC ACID B	INACTIVE
14	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIC ACID B	WEAK ACTIVITY
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GANODERIC ACID C-1	None
16	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIC ACID C-1	INACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIC ACID C-1	INACTIVE
18	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIC ACID C-1	WEAK ACTIVITY
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GANODERIC ACID H	None
20	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERIC ACID H	INACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GANODERIC ACID H	INACTIVE
22	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIC ACID H	WEAK ACTIVITY
23	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GANODERIOL A	None
24	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERIOL A	INACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GANODERIOL A	INACTIVE
26	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIOL A	WEAK ACTIVITY
27	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GANODERIOL B	None
28	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERIOL B	WEAK ACTIVITY
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERIOL B	INACTIVE
30	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIOL B	WEAK ACTIVITY
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GANODERIOL F	None
32	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERIOL F	WEAK ACTIVITY
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GANODERIOL F	WEAK ACTIVITY
34	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERIOL F	WEAK ACTIVITY
35	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GANODERMANOTRIOL	None
36	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GANODERMANOTRIOL	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GANODERMANOTRIOL	WEAK ACTIVITY
38	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANODERMANOTRIOL	INACTIVE
39	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ERGOSTEROL	None
40	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERGOSTEROL	INACTIVE
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ERGOSTEROL	INACTIVE
42	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERGOSTEROL	INACTIVE
43	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ERGOSTEROL PEROXIDE	None
44	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERGOSTEROL PEROXIDE	INACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ERGOSTEROL PEROXIDE	WEAK ACTIVITY
46	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERGOSTEROL PEROXIDE	INACTIVE
47	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CEREVISTEROL	None
48	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CEREVISTEROL	INACTIVE
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEREVISTEROL	WEAK ACTIVITY
50	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CEREVISTEROL	INACTIVE
51	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:	None
52	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:	INACTIVE
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:	WEAK ACTIVITY
54	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:	WEAK ACTIVITY

Citation 81523

Citation Details

Summary

Organisms and Their Experiments (1)

Ganoderma lucidum (GANODERMATACEAE)

Show SPARQL Queries (1)

Query 1